Thank you ACRO for entrusting the roles of Delegate and Alternate Delegate to the American Medical Association House of Delegates (HOD) to Dr. Mohamed Khan & myself. Very grateful for the opportunity to serve 🙏🤓😌 #StrongerTogether #RepresentationMatters linkedin.com/posts/annambrow…

Huge congratulations to outstanding mentee & long-time @DrMcClellandLab member Dr. Yorleny Vicioso-Mora MD PhD (@YorlenyVicioso) of @DukeRadOnc for winning an @ASCO @ConquerCancerFd Young Investigator Award!! #RadOnc #WomenWhoCurie #SiSePuede #ASCO26 #RepresentationMatters

ATTN NEBRASKA MEDICAID Drew Gonshorowski Director of Medicaid & Long Term Care Nebraska Department of Health and Human Services 301 Centennial Mall South, 3rd Floor PO Box 95026 Lincoln, NE 68509-5026 drew.gonshorowski@nebraska.gov Re: Urgent Request to Update and Correct Medicaid Payment Rates for Radiation Oncology Services – CPT® Codes 77402, 77407, and 77412 Dear Director: I am writing to you in my capacity as Chairman of R3 and CEO of RC Billing with clients in Nebraska to express grave concern regarding the current Nebraska reimbursement rates for essential radiation oncology treatment delivery and guidance services. These outdated rates are unsustainable, severely undermine the financial viability of providing high-quality radiation therapy, and place timely access to care at serious risk for Nebraska beneficiaries who require this life-saving treatment for cancer if these facilities are forced to halt services. The Nebraska rates for the revised radiation treatment codes are as follows: · CPT 77402 (Radiation delivery, Level 1): $116.54 · CPT 77407 (Radiation delivery, Level 2): $143.68 · CPT 77412 (Radiation delivery, Level 3): $169.40 These rates are catastrophically low and do not come close to covering the actual costs of delivering safe, precise, and effective radiation therapy. Radiation oncology requires substantial capital investment in linear accelerators, imaging systems, quality assurance, physics support, and highly trained clinical staff. At these reimbursement levels, practices cannot absorb the ongoing operational expenses, leading to reduced capacity, delayed treatments, or complete discontinuation of services for Nebraska patients in many communities. This directly jeopardizes patient outcomes in a vulnerable population that already faces barriers to care. By comparison, national Medicare benchmarks for these same services (updated effective January 1, 2026, under the revised CPT coding structure that bundles technical image guidance into the delivery codes) are substantially higher and reflect the true resources involved: · CPT 77402 (Level 1): approximately $79.49 (PFS non-facility) to $104.24 (HOPPS) · CPT 77407 (Level 2): approximately $317.64 (PFS non-facility) to $394.05 (HOPPS) · CPT 77412 (Level 3): approximately $391.46 (PFS non-facility) to $564.51 (HOPPS) Nebraska’s rates are lower than Medicare creating an untenable disparity. These national rates, while not extravagant, at least allow practices to maintain operations and invest in modern technology required for accurate, image-guided treatment. The situation is urgent. Radiation therapy is a cornerstone of curative and palliative cancer care in which approximately 60% of cancer patients receive radiation therapy at some point in their treatment journey. Inadequate reimbursement threatens provider participation in Nebraska networks, reduces geographic access (particularly in underserved areas), and risks poorer survival outcomes and increased downstream costs to the state from unmanaged disease progression. We respectfully request that your appropriate team immediately review and align Nebraska payment rates for CPT codes 77402, 77407, and 77412 with national Medicare benchmarks (or a reasonable cost-based equivalent) to ensure continued access to these critical services. We are available to provide additional data, cost analyses, or meet with your team to discuss this matter promptly. Thank you for your immediate attention to this critical patient-access issue. We look forward to your response and collaborative action to protect Nebraska beneficiaries’ access to radiation oncology care. Sincerely, Ron DiGiaimo MBA FACHE Chairman of R3 and CEO of RC Billing ron.digiaimo@rccsinc.com @ACRORadOnc @ACROSeals @ASTRO_org @CancerExecs @ACCCBuzz @ASRT @OfficialRCCSInc

Missed the livestream? The Radiopharmaceutical Therapies Webinar Series is available onDemand! This series is divided into two one-hour sessions, one focusing on 177Lu-Dotatate and the other on 177Lu-PSMA-617. Moderated by Ravi Patel, MD, PhD with speakers Neil Taunk, MD, MS and Mallika Marar, MD, MBA. Available now: ow.ly/3XCR50YVGX3 @NeilTaunkMD @mallika_marar

EXCELLENT!

EXCELLENT! @ASTRO_org @ACRORadOnc

ATTN Oklahoma: Melissa Miller Medicaid Director Oklahoma of Oklahoma, Oklahoma Health Care Authority 4345 N. Lincoln Blvd. Oklahoma City, OK 73105 melissa.miller@okhca.org Re: Urgent Request to Update and Correct Medicaid Payment Rates for Radiation Oncology Services – CPT® Codes 77387, 77402, 77407, and 77412 Dear Medicaid Director: I am writing to you in my capacity as Chairman of R3 and CEO of RC Billing with clients in Oklahoma to express grave concern regarding the current Oklahoma reimbursement rates for essential radiation oncology treatment delivery and guidance services. These outdated rates are unsustainable, severely undermine the financial viability of providing high-quality radiation therapy, and place timely access to care at serious risk for Oklahoma beneficiaries who require this life-saving treatment for cancer if these facilities are forced to halt services. The rates for the revised radiation treatment codes are as follows: · CPT 77387 (IGRT): $32.61 · CPT 77402 (Radiation treatment delivery, Level 1): $68.63 · CPT 77407 (Radiation treatment delivery, Level 2): $258.94 · CPT 77412 (Radiation treatment delivery, Level 3): $370.62 These rates are low, in particular our highest utilized code 77407 as well as 77402 and do not come close to covering the actual costs of delivering safe, precise, and effective radiation therapy. Radiation oncology requires substantial capital investment in linear accelerators, imaging systems, quality assurance, physics support, and highly trained clinical staff. At these reimbursement levels, practices cannot absorb the ongoing operational expenses, leading to reduced capacity, delayed treatments, or complete discontinuation of services for Oklahoma patients in many communities. This directly jeopardizes patient outcomes in a vulnerable population that already faces barriers to care. By comparison, national Medicare benchmarks for these same services (updated effective January 1, 2026, under the revised CPT coding structure that bundles technical image guidance into the delivery codes) are substantially higher and reflect the true resources involved: · CPT 77387 (professional component only): approximately $36.74 (Medicare PFS non-facility; commercial payers often reimburse $100–$130) · CPT 77402 (Level 1): approximately $79.49 (PFS non-facility) to $104.24 (HOPPS) · CPT 77407 (Level 2): approximately $317.64 (PFS non-facility) to $394.05 (HOPPS) · CPT 77412 (Level 3): approximately $391.46 (PFS non-facility) to $564.51 (HOPPS) Oklahoma’s rates are lower than Medicare’s creating an untenable disparity. These national rates, while not extravagant, at least allow practices to maintain operations and invest in modern technology required for accurate, image-guided treatment. The situation is urgent. Radiation therapy is a cornerstone of curative and palliative cancer care in which approximately 60% of cancer patients receive radiation therapy at some point in their treatment journey. Inadequate reimbursement threatens provider participation in Oklahoma networks, reduces geographic access (particularly in underserved areas), and risks poorer survival outcomes and increased downstream costs to the state from unmanaged disease progression. We respectfully request that your appropriate team immediately review and align Oklahoma payment rates for CPT codes 77402 and 77407with national Medicare benchmarks (or a reasonable cost-based equivalent) to ensure continued access to these critical services. We are available to provide additional data, cost analyses, or meet with your team to discuss this matter promptly. Thank you for your immediate attention to this critical patient-access issue. We look forward to your response and collaborative action to protect Oklahoma beneficiaries’ access to radiation oncology care. Sincerely, Ron DiGiaimo MBA FACHE Chairman of R3 and CEO of RC Billing ron.digiaimo@rccsinc.com @OfficialRCCSInc #radonc

ATTN Nevada: Ann Jensen Medicaid Administrator State of Nevada, Dept. of Health & Human Services; Division of Health Care Financing & Policy 1100 East William Street, Suite 101 Carson City, NV 89710 ajensen@nvha.nv.gov Re: Urgent Request to Update and Correct Medicaid Payment Rates for Radiation Oncology Services – CPT® Codes 77387, 77402, 77407, and 77412 Dear Medicaid Administrator: I am writing to you in my capacity as Chairman of R3 and CEO of RC Billing with clients in Nevada to express grave concern regarding the current Nevada reimbursement rates for essential radiation oncology treatment delivery and guidance services. These outdated rates are unsustainable, severely undermine the financial viability of providing high-quality radiation therapy, and place timely access to care at serious risk for Nevada beneficiaries who require this life-saving treatment for cancer if these facilities are forced to halt services. The rates for the revised radiation treatment codes are as follows: · CPT 77387 (IGRT): $ NOT LISTED ON FEE SCHEDULE · CPT 77402 (Rad treatment delivery, Level 1): $147.79 · CPT 77407 (Rad treatment delivery, Level 2): $268.35 · CPT 77412 (Radtreatment delivery, Level 3): $254.74 These rates are catastrophically low and do not come close to covering the actual costs of delivering safe, precise, and effective radiation therapy. Radiation oncology requires substantial capital investment in linear accelerators, imaging systems, quality assurance, physics support, and highly trained clinical staff. At these reimbursement levels, practices cannot absorb the ongoing operational expenses, leading to reduced capacity, delayed treatments, or complete discontinuation of services for Nevada patients in many communities. This directly jeopardizes patient outcomes in a vulnerable population that already faces barriers to care. By comparison, national Medicare benchmarks for these same services (updated effective January 1, 2026, under the revised CPT coding structure that bundles technical image guidance into the delivery codes) are substantially higher and reflect the true resources involved: · CPT 77387 (pro component only): approx $36.74 · CPT 77402 (Level 1): approx $79.49 (PFS non-facility) to $104.24 (HOPPS) · CPT 77407 (Level 2): approx $317.64 (PFS non-facility) to $394.05 (HOPPS) · CPT 77412 (Level 3): approx $391.46 (PFS non-facility) to $564.51 (HOPPS) Nevada’s rates are lower than Medicare’s creating an untenable disparity. Many commercial payers reimburse at even higher levels. These national rates, while not extravagant, at least allow practices to maintain operations and invest in modern technology required for accurate, image-guided treatment. The situation is urgent. Radiation therapy is a cornerstone of curative and palliative cancer care in which approximately 60% of cancer patients receive radiation therapy at some point in their treatment journey. Inadequate reimbursement threatens provider participation in Nevada networks, reduces geographic access (particularly in underserved areas), and risks poorer survival outcomes and increased downstream costs to the state from unmanaged disease progression. We respectfully request that your appropriate team immediately review and align Nevada payment rates for CPT codes 77387, 77402, 77407, and 77412 with national Medicare benchmarks (or a reasonable cost-based equivalent) to ensure continued access to these critical services. We are available to provide additional data, cost analyses, or meet with your team to discuss this matter promptly. Thank you for your immediate attention to this critical patient-access issue. We look forward to your response and collaborative action to protect Nevada beneficiaries’ access to radiation oncology care. Sincerely, Ron DiGiaimo MBA FACHE Chairman of R3 and CEO of RC Billing ron.digiaimo@rccsinc.com @OfficialRCCSInc

I just donated to the 2026 Rush to Crush Cancer. Go to fundraisers.rushtocrushcance… via @R2C_Cancer

Please consider supporting our cancer research! donate.rushtocrushcancer.org…

#ASTROAdvocacy for #radonc & #cancer patients: 1. #FixPriorAuth by signing bipartisan letter @RepDelBene @MikeKellyPA @RepBera @RepLarryBucshon 2. Reform Medicare payments @CMSGov 3. Increase research funding @NIH @theNCI @ARPA_H @ASTRO_org @CancerAdvocacy #CancerSurvivorship

Wrapping up residency? Before you lose access to your academic inbox, take a minute to update your contact info with ACRO so we can stay connected. Update by Aug. 30 for a chance to win a $250 voucher.

Excited for this important conference! Can’t wait to see you all there!

Now more than ever is the time! @ACROSeals @ACRORadOnc

We need your voice! Please complete this survey so we can turn advocacy into action! #radonccuts

#ASTROAdvocacy & oncology partners in action. The issues are real & we need action. @ASTRO_org members can quickly send a message to @DrOzCMS about how new codes are impacting your practice. astro.org/advocacy/key-issue…

Thank you @RepJohnJoyce for championing this issue as a PA representative serving Altoona, Johnstown, and the USA! We need your voice to allow us to serve Pennsylvania and the country! @CMSGov @DrOzCMS @HSkinnerMDPhD @UzomaMDPhD @Haleyml1987

Thank you to #ROCR Act champion @RepJohnJoyce for today's question to @SecKennedy about radiation oncology’s payment crisis. We appreciate that Sec Kennedy committed to work with Dr. Joyce & the radonc community to protect access to cancer care, especially in rural areas. @CMSGov @DrOzCMS @HHSGov #ASTROAdvocacy ow.ly/h7Tm50YNF7L @HouseCommerce @repguthrie @RepMGriffith

Tell CMS How Coding Changes are Impacting You! votervoice.net/Shares/BtMJwA…